Effects of 10 mg Monacolins on Vascular Health: a Clinical Trial

Overview

This will be a double-blind randomized clinical trial carried out on subjects with suboptimal control of LDL-cholesterolemia, following a Mediterranean diet, and treated with a red yeast rice extract (containing 10 mg monacolin K per daily dose) or placebo, in order to evaluate the middle-term effects on vascular health evaluated by non invasive methods (Vicorder(R) apparatus)

Full Title of Study: “Double-blind, Randomized Clinical Trial on the Middle-term Effect of the Red Yeast Rice Intake on Endothelial Function and Arterial Stiffness in Subjects With Suboptimal LDL-cholesterol Level in the Context of the Mediterranean Diet”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Triple (Participant, Care Provider, Investigator)
  • Study Primary Completion Date: June 2015

Interventions

  • Dietary Supplement: Red yeast rice
    • 1 capsule to be taken before to sleep, each day, for 6 months
  • Dietary Supplement: Placebo

Arms, Groups and Cohorts

  • Active Comparator: Red yeast rice
    • Red yeast rice extract 200 mg, containing 10 mg monacolin K per daily dose, 1 capsule per day, per 6 months
  • Placebo Comparator: Placebo
    • Placebo 200 mg (neutral fibre), 1 capsule per day, per 6 months

Clinical Trial Outcome Measures

Primary Measures

  • Flow mediated dilation (FMD) change from the baseline to the end of treatment period
    • Time Frame: 6 months

Secondary Measures

  • 12 hour fasting LDL-cholesterolemia change from the baseline to the end of treatment period
    • Time Frame: 6 months

Participating in This Clinical Trial

Inclusion Criteria

  • LDL-cholesterol between 130 and 190 mg/dL Exclusion Criteria:

  • Secundary prevention for cardiovascular disease – Type 2 diabetes – Assumption of lipid-lowering drug or dietary supplements – Previous intolerans to read yeast rice including dietary supplements

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 70 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University of Bologna
  • Provider of Information About this Clinical Study
    • Principal Investigator: Claudio Borghi, Professor Claudio Borghi – University of Bologna

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.